Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Chilam Chan

6PUBLICATIONS

25CO-AUTHORS

Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumours

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|May 13, 2025

The Efficacy of Targeted Monoclonal IgA Antibodies Against Pancreatic Ductal Adenocarcinoma.

Léon Raymakers, Elsemieke M Passchier, Meggy E L Verdonschot

|Mar 05, 2025

Engineering of anticancer human immunoglobulin A equipped with albumin for enhanced plasma half-life.

Simone Mester, Chilam Chan, Marta Lustig

|Jul 03, 2024

Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.0.

Chilam Chan, J H Marco Jansen, Ilona S T Hendriks

|May 23, 2024

Enhancing IgA-mediated neutrophil cytotoxicity against neuroblastoma by CD47 blockade.

Chilam Chan, Marjolein Stip, Maaike Nederend

|Jul 14, 2023

Sialic Acids on Tumor Cells Modulate IgA Therapy by Neutrophils via Inhibitory Receptors Siglec-7 and Siglec-9.

Chilam Chan, Marta Lustig, J H Marco Jansen

|Nov 11, 2022

Effective, Long-Term, Neutrophil Depletion Using a Murinized Anti-Ly-6G 1A8 Antibody.

Patricia A Olofsen, Marjolein C Stip, J H Marco Jansen

Pageof 1

Frequent Collaborators

3 joint publications

Patricia A Olofsen

3 joint publications

Jeanette Leusen

3 joint publications

Thomas Valerius

2 joint publications

Marjolein Stip

2 joint publications

Leon Raymakers

2 joint publications

J H Marco Jansen

2 joint publications

Meggy E L Verdonschot

1 joint publications

Laura Garcia Villagrasa

1 joint publications

Ilona S T Hendriks

1 joint publications

Ida C van der Peet

Frequent Collaborators

3 joint publications

Patricia A Olofsen

3 joint publications

Jeanette Leusen

3 joint publications

Thomas Valerius

2 joint publications

Marjolein Stip

Top Related Videos

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation <em>In Vivo</em> and Decreasing Galactose-Deficient IgA1 Production <em>In Vitro</em>

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation <em>In Vivo</em> and Decreasing Galactose-Deficient IgA1 Production <em>In Vitro</em>

Published on : Oct 13, 2023

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on : Mar 08, 2018

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on : May 22, 2020

See more related videos

Top Related Videos

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation <em>In Vivo</em> and Decreasing Galactose-Deficient IgA1 Production <em>In Vitro</em>

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation <em>In Vivo</em> and Decreasing Galactose-Deficient IgA1 Production <em>In Vitro</em>

Published on : Oct 13, 2023

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on : Mar 08, 2018

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on : May 22, 2020

See more related videos